CIK 0000310158 · Large accelerated filer
Merck & Co., Inc.
Sign in to watch- Ticker
- MRK
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NJ
- Entity type
- operating
- EIN
- 221918501
- Phone
- 908-740-4000
- Business address
- 126 EAST LINCOLN AVENUE, P.O. BOX 2000, RAHWAY, NJ, 07065
- Former names
- Merck & Co. Inc., SCHERING PLOUGH CORP
- 4 Option exercise Executive VP & President, MRL acquired 4,722 shares (option exercise)
- 4 Option exercise EVP, General Counsel acquired 2,951 shares (option exercise)
- 4 Option exercise EVP, Chief HR Officer acquired 13,435 shares (option exercise)
- 4 Option exercise EVP & CFO acquired 3,935 shares (option exercise)
- 4 Option exercise Chairman, CEO & President acquired 13,300 shares (option exercise)
- 4 Option exercise EVP, Oncology & Int?l acquired 1,377 shares (option exercise)
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 8-K Event Results of operations
- SC TO-T/A Deal Tender Offer Statement
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- SC TO-T Deal Tender Offer Statement
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 3 Insider Initial Statement of Ownership
- 10-K Report Annual Report
- 13F-HR Other Quarterly Holdings of Institutional Investment Managers
Page 5 of 152 · 3,037 filings